Telemedicine in Functional Motor Disorder (TeleFMD)
Functional Movement Disorder
About this trial
This is an interventional treatment trial for Functional Movement Disorder focused on measuring Telemedicine, Gait, Economic costs, Pain, Fatigue
Eligibility Criteria
Inclusion Criteria:
- a clinically definite diagnosis of FMDs based on Gupta and Lang diagnostic criteria with the presence of distractibility maneuvers and a demonstration of positive signs;
- the presence of 1 (isolated FMDs) or more clinical motor symptoms (combined FMDs), including weakness, tremor, jerks, dystonia, gait disorders, and parkinsonism;
- acceptable level of digital skills.
Exclusion Criteria:
- prominent dissociative seizures
- prominent cognitive and physical impairment that precludes signing the informed consent for participation in the study;
- unable or refuse to attend the consecutive 5-day rehabilitation treatment
Sites / Locations
- USD Parkinson's Disease and Movement Disorders UnitRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Telemedicine Group
Control Group
Patients will receive an individualized intensive 5-day rehabilitation program (2 hours/day, five days/week, one week) by a qualified physiotherapist at the USD Parkinson's Disease and Movement Disorders Unit of Verona (Italy) followed by an individualized self-management program implemented with the Digital Telemedicine platform support ((PHOEMA G.P.I PLATFORM, GPI spa, Trento, Italy). Telemedicine will consist of 24 tele-sessions (1 h/day, one day/week, 24 weeks) and two self-management sessions (1 h/day, two days/week, 24 weeks). For each patient, the duration of the activity, number of steps taken, distance traveled (km), Kcal consumed, duration of inactivity, total hours of sleep, and number of training sessions performed will be monitored through Polar Vantage M devices.
Patients will receive the same individualized intensive 5-day rehabilitation program (2 hours/day, 5 days/week, 1 week) of the Telemedicine Group by a qualified physiotherapist at the USD Parkinson's Disease and Movement Disorders Unit of Verona (Italy) followed by a home-based self-management plan (Treatment, as usual, 1 h/day, 3 days/week, 24 weeks) without any Digital Telemedicine platform support.